HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

João V Nani Selected Research

Neoplasms (Cancer)

11/2023Evaluation of tumor growth remission in a murine model for subcutaneous solid tumors - Benefits of associating the antitumor agent crotamine with mesoporous nanosilica particles to achieve improved dosing frequency and efficacy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


João V Nani Research Topics

Disease

11Schizophrenia (Dementia Praecox)
11/2023 - 01/2019
4Mental Disorders (Mental Disorder)
11/2023 - 12/2019
4Psychotic Disorders (Schizoaffective Disorder)
10/2020 - 01/2019
3Bipolar Disorder (Manic Depressive Psychosis)
01/2021 - 12/2019
1Melanoma (Melanoma, Malignant)
11/2023
1Neoplasms (Cancer)
11/2023
1Brain Diseases (Brain Disorder)
01/2023
1Neurodegenerative Diseases (Neurodegenerative Disease)
01/2023
1Microcephaly
01/2023
1Zika Virus Infection
01/2023
1Treatment-Resistant Schizophrenia
01/2020

Drug/Important Bio-Agent (IBA)

6Biomarkers (Surrogate Marker)IBA
11/2023 - 01/2019
6Antipsychotic Agents (Antipsychotics)IBA
10/2020 - 01/2019
5oligopeptidaseIBA
11/2023 - 01/2019
5EnzymesIBA
01/2023 - 01/2019
4ElementsIBA
10/2022 - 01/2019
2Proteins (Proteins, Gene)FDA Link
01/2021 - 01/2020
2Polytetrafluoroethylene (Teflon)FDA Link
07/2020 - 01/2019
2Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
07/2020 - 01/2020
2Risperidone (Risperdal Consta)FDA LinkGeneric
07/2020 - 01/2019
1crotamineIBA
11/2023
1SBA-15IBA
11/2023
1Antineoplastic Agents (Antineoplastics)IBA
11/2023
1InterferonsIBA
01/2023
1AngiotensinsIBA
01/2023
1Peptides (Polypeptides)IBA
01/2023
1Angiotensin Receptor AntagonistsIBA
01/2023
1Complement System Proteins (Complement)IBA
01/2023
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
01/2023
1N-(2-acetamido)-2-aminoethanesulfonic acid (ACES)IBA
01/2023
1Amphetamine (Amfetamine)FDA LinkGeneric
01/2020
1Dopamine (Intropin)FDA LinkGeneric
01/2020
1Peptide Hydrolases (Proteases)FDA Link
01/2020
1MercuryIBA
01/2020
14-O-carboxymethylascochlorinIBA
12/2019
1HydroxydopaminesIBA
12/2019
1Messenger RNA (mRNA)IBA
01/2019

Therapy/Procedure

1Oral Administration
11/2023
1Drug Therapy (Chemotherapy)
11/2023
1Aftercare (After-Treatment)
07/2020